PROVIDE-HF: Patient Reported Outcomes inVestigation following Initiation of Drug therapy with Entresto (Valsartan/Sacubitril) in Heart Failure.
Clinical Trial Grant
Awarded By
Novartis Pharmaceuticals Corporation
Start Date
May 12, 2017
End Date
June 30, 2020
Awarded By
Novartis Pharmaceuticals Corporation
Start Date
May 12, 2017
End Date
June 30, 2020